Drdgold Market Risk Adjusted Performance
| DRDGF Stock | | | USD 2.62 -0.53 -16.83% |
The Market Risk Adjusted Performance profile for Drdgold is based on historical price and volume observations. All inputs reflect available trading data across supported markets. Drdgold has a market cap of 674.43 M, operating margin of 23.87%, ROE of 21.91%. See
Investing Opportunities for portfolio-level analysis. Portfolio positioning is summarized for reference. Position-level data supports the allocation summary. A position in Drdgold is part of the allocation. It is reflected in the overall portfolio structure. How positions are weighted depends on the construction approach used. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in census.
Drdgold has current Market Risk Adjusted Performance of 0.1438.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.1438 | |
| ER[a] | = | Expected return on investing in Drdgold |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Drdgold ranks
fifth among pink sheets in market risk adjusted performance across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set at roughly
201.04 Maximum Drawdown per unit of Market Risk Adjusted Performance. Drdgold carries a
201.04 x Maximum Drawdown-to-Market Risk Adjusted Performance ratio
Other Technical Indicators